首页> 美国卫生研究院文献>Frontiers in Molecular Neuroscience >Development of Efficient AAV2/DJ-Based Viral Vectors to Selectively Downregulate the Expression of Neuronal or Astrocytic Target Proteins in the Rat Central Nervous System
【2h】

Development of Efficient AAV2/DJ-Based Viral Vectors to Selectively Downregulate the Expression of Neuronal or Astrocytic Target Proteins in the Rat Central Nervous System

机译:有效的基于AAV2 / DJ的病毒载体的开发以选择性下调大鼠中枢神经系统中神经元或星形胶质靶蛋白的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Viral vectors have become very popular to overexpress or downregulate proteins of interest in different cell types. They conveniently allow the precise targeting of well-defined tissue areas, which is particularly useful in complex organs like the brain. In theory, each vector should have its own cell specificity that can be obtained by using different strategies (e.g., using a cell-specific promoter). For the moment, there is few vectors that have been developed to alternatively target, using the same capsid, neurons and astrocytes in the central nervous system. There is even fewer examples of adeno-associated viral vectors able to efficiently transduce cells both in vitro and in vivo. The development of viral vectors allowing the cell-specific downregulation of a protein in cultured cells of the central nervous system as well as in vivo within a large brain area would be highly desirable to address several important questions in neurobiology. Here we report that the use of the AAV2/DJ viral vector associated to an hybrid CMV/chicken β-actin promoter (CBA) or to a modified form of the glial fibrillary acidic protein promoter (G1B3) allows a specific transduction of neurons or astrocytes in more than half of the barrel field within the rat somatosensory cortex. Moreover, the use of the miR30E-shRNA technology led to an efficient downregulation of two proteins of interest related to metabolism both in vitro and in vivo. Our results demonstrate that it is possible to downregulate the expression of different protein isoforms in a cell-specific manner using a common serotype. It is proposed that such an approach could be extended to other cell types and used to target several proteins of interest within the same brain area.
机译:病毒载体在不同细胞类型中过表达或下调目的蛋白变得非常流行。它们方便地实现精确定义组织区域的精确定位,这在诸如大脑的复杂器官中特别有用。从理论上讲,每个载体应具有其自己的细胞特异性,该特异性可以通过使用不同的策略(例如,使用细胞特异性启动子)来获得。目前,在中枢神经系统中使用相同的衣壳,神经元和星形胶质细胞的替代载体很少。能够在体外和体内有效转导细胞的腺相关病毒载体的例子甚至更少。为了解决神经生物学中的几个重要问题,迫切需要开发病毒载体以使蛋白质在中枢神经系统的培养细胞中以及在大脑区域的体内具有细胞特异性的下调。在这里我们报告说,使用与混合CMV /鸡β-肌动蛋白启动子(CBA)或神经胶质原纤维酸性蛋白启动子(G1B3)的修饰形式相关的AAV2 / DJ病毒载体,可以对神经元或星形胶质细胞进行特异性转导在大鼠体感皮质内的桶形区域的一半以上。此外,miR30E-shRNA技术的使用导致体内和体内代谢相关的两种目的蛋白的有效下调。我们的结果表明,可以使用常见的血清型以细胞特异性方式下调不同蛋白质同工型的表达。建议将这种方法扩展到其他细胞类型,并用于靶向同一大脑区域内的几种目标蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号